How is this possible?
Even in the talk they said uses were quickly going 'sky high'.
Can someone who's regularly in contact with the team check on this? This would have significant impacts on revenue that we thought we're getting.
- Forums
- ASX - By Stock
- RAP
- Ann: Alodokter to launch ResAppDx in Indonesia
Ann: Alodokter to launch ResAppDx in Indonesia, page-338
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)